National service framework's financial implications are huge

BMJ 2000; 321 doi: 10.1136/bmj.321.7262.705 (Published 16 September 2000)
Cite this as: BMJ 2000;321:705.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Anthony S Wierzbicki, senior lecturer in chemical pathology,
  2. Timothy M Reynolds, professor of chemical pathology
  1. St Thomas's Hospital, London SE1 7EH
  2. Queen's Hospital, Burton-on-Trent DE13 0RB

    EDITOR—We are delighted that tools for assessment of risk of cardiovascular disease have been addressed in a whole issue of the BMJ.1 It is unfortunate that so many calculators (Sheffield mark 2; New Zealand mark 2) cannot agree on definitions and may not in fact give the same results for each patient.2 We have compared 10 risk algorithms, and, while the Sheffield tables underestimate risk in patients with diabetes at 3% per year, the revised (but not the old) New Zealand guidelines match the performance of other guidelines: …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL